NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Globus Medical, Inc. ("Globus" or the "Company") (NYSE:GMED) on behalf of Globus stockholders. Our investigation concerns whether Globus has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On August 13, 2024, in a filing with the U.S. Securities and Exchange Co ...

NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globus Medical, Inc. ("Globus Medical" or "the Company") (NYSE: GMED). Investors who purchased Globus Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GMED. Investigation Details On August 13, 2024, in a filing with the U.S. Securities and Exchange Commission, Gl ...

Globus Medical, Inc. (GMED) reported second-quarter 2024 adjusted earnings per share (EPS) of 75 cents, which beat the Zacks Consensus Estimate by 10.3%. The figure increased 19% year over year. The adjusted EPS excludes certain non-recurring expenses and benefits, such as the amortization of intangibles, merger and acquisition-related costs/licensing and provision for litigation, among others. Without adjustments, the company registered a GAAP diluted EPS of 23 cents, down 59.6% from the year-ago quarter's ...

Globus Medical, Inc. (NYSE:GMED) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Daniel Scavilla - President and CEO Keith Pfeil - COO and CFO Conference Call Participants Matthew Miksic - Barclays Vikramjeet Chopra - Wells Fargo Shagun Singh - RBC CM Steve Lichtman - Oppenheimer David Saxon - Needham & Company Matthew O'Brien - Piper Sandler Jason Wittes - ROTH Matthew Blackman - Stifel Ryan Zimmerman - BTIG Ravi Mishra - Tru ...

Globus Medical (GMED) reported $629.69 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 115.9%. EPS of $0.75 for the same period compares to $0.63 a year ago. The reported revenue represents a surprise of +2.39% over the Zacks Consensus Estimate of $615 million. With the consensus EPS estimate being $0.68, the EPS surprise was +10.29%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall ...

Globus Medical (GMED) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.63 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 10.29%. A quarter ago, it was expected that this medical device company would post earnings of $0.55 per share when it actually produced earnings of $0.72, delivering a surprise of 30.91%. Over the last four quarte ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 04-3744954 (State or othe ...

Exhibit 99.1 Globus Medical Reports Second Quarter 2024 Results AUDUBON, PA, August 6, 2024: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2024. · Worldwide net sales were $629.7 million, an increase of 115.9% or 117.3% on a constant currency basis · GAAP net income for the quarter was $31.8 million · GAAP diluted earnings per share ("EPS") was $0.23 and non-GAAP diluted EPS was $0.75 · Non-GAAP adjusted E ...

AUDUBON, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2024. Worldwide net sales were $629.7 million, an increase of 115.9% or 117.3% on a constant currency basis GAAP net income for the quarter was $31.8 million GAAP diluted earnings per share ("EPS") was $0.23 and non-GAAP diluted EPS was $0.75 Non-GAAP adjusted EBITDA was $190.4 million, or 30.2% of net sales "I'm ...

Globus Medical is gaining market share in the musculoskeletal solutions space, banking on the strong performance of its implantable devices, biologics, accessories and unique surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. In line with the company's business strategy to focus on its integrated product development, Globus Medical is consistently making efforts in research and development. Per the company, its team-oriented approach, active surgeon input and ...